These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 39204060)

  • 1. Measles Population Immunity Profiles: Updated Methods and Tools.
    Li X; Goodson JL; Perry RT
    Vaccines (Basel); 2024 Aug; 12(8):. PubMed ID: 39204060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges Addressing Inequalities in Measles Vaccine Coverage in Zambia through a Measles-Rubella Supplementary Immunization Activity during the COVID-19 Pandemic.
    Yang Y; Kostandova N; Mwansa FD; Nakazwe C; Namukoko H; Sakala C; Bobo P; Masumbu PK; Nachinga B; Ngula D; Carcelen AC; Prosperi C; Winter AK; Moss WJ; Mutembo S
    Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Added value of the measles-rubella supplementary immunization activity in reaching unvaccinated and under-vaccinated children, a cross-sectional study in five Indian districts, 2018-20.
    Prosperi C; Thangaraj JWV; Hasan AZ; Kumar MS; Truelove S; Kumar VS; Winter AK; Bansal AK; Chauhan SL; Grover GS; Jain AK; Kulkarni RN; Sharma SK; Soman B; Chaaithanya IK; Kharwal S; Mishra SK; Salvi NR; Sharma NP; Sharma S; Varghese A; Sabarinathan R; Duraiswamy A; Rani DS; Kanagasabai K; Lachyan A; Gawali P; Kapoor M; Chonker SK; Cutts FT; Sangal L; Mehendale SM; Sapkal GN; Gupta N; Hayford K; Moss WJ; Murhekar MV
    Vaccine; 2023 Jan; 41(2):486-495. PubMed ID: 36481106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measles control in Sub-Saharan Africa: South Africa as a case study.
    Verguet S; Jassat W; Hedberg C; Tollman S; Jamison DT; Hofman KJ
    Vaccine; 2012 Feb; 30(9):1594-600. PubMed ID: 22230581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of measles supplementary immunization activities on reaching children missed by routine programs.
    Portnoy A; Jit M; Helleringer S; Verguet S
    Vaccine; 2018 Jan; 36(1):170-178. PubMed ID: 29174680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of potentially achievable vaccination coverage of the second dose of measles containing vaccine with simultaneous administration and risk factors for missed opportunities among children in Zhejiang province, east China.
    Hu Y; Chen Y; Wang Y; Liang H
    Hum Vaccin Immunother; 2018 Apr; 14(4):875-880. PubMed ID: 29252094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The importance of supplementary immunisation activities to prevent measles outbreaks during the COVID-19 pandemic in Kenya.
    Mburu CN; Ojal J; Chebet R; Akech D; Karia B; Tuju J; Sigilai A; Abbas K; Jit M; Funk S; Smits G; van Gageldonk PGM; van der Klis FRM; Tabu C; Nokes DJ; ; Scott J; Flasche S; Adetifa I
    BMC Med; 2021 Feb; 19(1):35. PubMed ID: 33531015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measles epidemic in Romania, 1996-1998: assessment of vaccine effectiveness by case-control and cohort studies.
    Hennessey KA; Ion-Nedelcu N; Craciun MD; Toma F; Wattigney W; Strebel PM
    Am J Epidemiol; 1999 Dec; 150(11):1250-7. PubMed ID: 10588086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of measles supplementary immunization activities and the implications for Pacific Island countries and territories.
    Clements CJ; Soakai TS; Sadr-Azodi N
    Expert Rev Vaccines; 2017 Feb; 16(2):161-174. PubMed ID: 27690704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization delivery in the second year of life in Ghana: the need for a multi-faceted approach.
    Nyaku M; Wardle M; Eng JV; Ametewee L; Bonsu G; Larbi Opare JK; Conklin L
    Pan Afr Med J; 2017; 27(Suppl 3):4. PubMed ID: 29296139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the cost-effectiveness of different measles vaccination strategies for children in the Democratic Republic of Congo.
    Doshi RH; Eckhoff P; Cheng A; Hoff NA; Mukadi P; Shidi C; Gerber S; Wemakoy EO; Muyembe-Tafum JJ; Kominski GF; Rimoin AW
    Vaccine; 2017 Oct; 35(45):6187-6194. PubMed ID: 28966000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?
    Lopez AS; Guris D; Zimmerman L; Gladden L; Moore T; Haselow DT; Loparev VN; Schmid DS; Jumaan AO; Snow SL
    Pediatrics; 2006 Jun; 117(6):e1070-7. PubMed ID: 16740809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demographics, epidemiology and the impact of vaccination campaigns in a measles-free world - Can elimination be maintained?
    Prada JM; Metcalf CJE; Takahashi S; Lessler J; Tatem AJ; Ferrari M
    Vaccine; 2017 Mar; 35(11):1488-1493. PubMed ID: 28216186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measles supplemental immunization activities improve measles vaccine coverage and equity: Evidence from Kenya, 2002.
    Vijayaraghavan M; Martin RM; Sangrujee N; Kimani GN; Oyombe S; Kalu A; Runyago A; Wanjau G; Cairns L; Muchiri SN
    Health Policy; 2007 Sep; 83(1):27-36. PubMed ID: 17174435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress Toward Measles Elimination - Western Pacific Region, 2013-2017.
    Hagan JE; Kriss JL; Takashima Y; Mariano KML; Pastore R; Grabovac V; Dabbagh AJ; Goodson JL
    MMWR Morb Mortal Wkly Rep; 2018 May; 67(17):491-495. PubMed ID: 29723171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress Toward Measles Elimination - European Region, 2009-2018.
    Zimmerman LA; Muscat M; Singh S; Ben Mamou M; Jankovic D; Datta S; Alexander JP; Goodson JL; O'Connor P
    MMWR Morb Mortal Wkly Rep; 2019 May; 68(17):396-401. PubMed ID: 31048675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress toward measles elimination--Western Pacific Region, 2009-2012.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Jun; 62(22):443-7. PubMed ID: 23739338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maintaining high rates of measles immunization in Africa.
    Lessler J; Moss WJ; Lowther SA; Cummings DA
    Epidemiol Infect; 2011 Jul; 139(7):1039-49. PubMed ID: 20920382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating age-specific vaccine effectiveness using data from a large measles outbreak in Berlin, Germany, 2014/15: evidence for waning immunity.
    Bitzegeio J; Majowicz S; Matysiak-Klose D; Sagebiel D; Werber D
    Euro Surveill; 2019 Apr; 24(17):. PubMed ID: 31039834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antecedent causes of a measles resurgence in the Democratic Republic of the Congo.
    Scobie HM; Ilunga BK; Mulumba A; Shidi C; Coulibaly T; Obama R; Tamfum JJ; Simbu EP; Smit SB; Masresha B; Perry RT; Alleman MM; Kretsinger K; Goodson J
    Pan Afr Med J; 2015; 21():30. PubMed ID: 26401224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.